A Trial to Determine Whether Two Differing Strength Tablets (3 x 5 mg Versus 1 x 15 mg) of Sublingually Org 5222 (Asenapine) Are Safe and Equal in Subjects With Schizophrenia or Schizoaffective Disorder (P05937)

Clinical trial NCT01101464 · COMPLETED

Trial details

NCT number: NCT01101464
Sponsor: Organon and Co
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Schizophrenia Schizoaffective Disorder

Start date: 2002-10-01
Primary completion: 2002-12-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.